Aquatic Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,269
| Closed | -$922K | – | 1224 |
|
|
2024
Q4 | $922K | Buy |
+50,269
| New | +$922K | 0.03% | 573 |
|
|
2024
Q2 | – | Sell |
-101,200
| Closed | -$1.87M | – | 1170 |
|
|
2024
Q1 | $1.87M | Buy |
101,200
+55,300
| +120% | +$1.02M | 0.06% | 262 |
|
|
2023
Q4 | $1.44M | Buy |
45,900
+23,100
| +101% | +$723K | 0.04% | 409 |
|
|
2023
Q3 | $475K | Buy |
+22,800
| New | +$475K | 0.02% | 489 |
|
|
2023
Q2 | – | Sell |
-71,600
| Closed | -$1.35M | – | 1281 |
|
|
2023
Q1 | $1.35M | Buy |
+71,600
| New | +$1.35M | 0.08% | 238 |
|
|
2022
Q4 | – | Sell |
-17,800
| Closed | -$291K | – | 1302 |
|
|
2022
Q3 | $291K | Buy |
+17,800
| New | +$291K | 0.03% | 533 |
|
|
2022
Q2 | – | Sell |
-1,400
| Closed | -$34K | – | 1142 |
|
|
2022
Q1 | $34K | Buy |
+1,400
| New | +$34K | 0.05% | 363 |
|